We are live on ! Find out more
TG

TLP Group Portfolio holdings

AUM $6.61M
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+18.07%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$14.9M
Cap. Flow
-$292K
Cap. Flow %
-0.2%
Top 10 Hldgs %
64.22%
Holding
794
New
229
Increased
159
Reduced
207
Closed
182

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$3.53M
2
PFE icon
Pfizer
PFE
+$2.63M
3
MRK icon
Merck
MRK
+$1.44M
4
AMGN icon
Amgen
AMGN
+$1.26M
5
LLY icon
Eli Lilly
LLY
+$976K

Top Sells

Rank Stock Value
1
AIMT
Aimmune Therapeutics
AIMT
+$30.2M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.96M
3
GM icon
General Motors
GM
+$484K
4
DSKEW
Daseke, Inc. Warrant
DSKEW
+$417K
5
TSLA icon
Tesla
TSLA
+$395K

Sector Composition

Rank Sector Weight
1 Healthcare 8.73%
2 Financials 6.69%
3 Consumer Discretionary 5.75%
4 Industrials 4.37%
5 Technology 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITT icon
126
ITT
ITT
$17.5B
$189K 0.13%
+3,533
New +$177K
RHI icon
127
Robert Half
RHI
$3.88B
$189K 0.13%
3,397
+3,372
+13,488% +$179K
RJF icon
128
Raymond James Financial
RJF
$32.4B
$189K 0.13%
+3,173
New +$183K
UGI icon
129
UGI
UGI
$7.92B
$189K 0.13%
4,034
-2,030
-33% -$97K
XL
130
DELISTED
XL Group Ltd.
XL
$189K 0.13%
5,376
-6,309
-54% -$245K
TCF
131
DELISTED
TCF Financial Corporation
TCF
$189K 0.13%
+9,204
New +$172K
APTV icon
132
Aptiv
APTV
$11.9B
$188K 0.13%
+2,211
New +$211K
GD icon
133
General Dynamics
GD
$103B
$188K 0.13%
926
-466
-33% -$95.2K
GNTX icon
134
Gentex
GNTX
$5.07B
$188K 0.13%
8,951
+8,912
+22,851% +$177K
HIW icon
135
Highwoods Properties
HIW
$3.62B
$188K 0.13%
3,698
-1,493
-29% -$77K
INGR icon
136
Ingredion
INGR
$6.32B
$188K 0.13%
1,342
+1,231
+1,109% +$162K
OPLN
137
Openlane
OPLN
$4.13B
$188K 0.13%
9,855
+8,949
+988% +$166K
MAN icon
138
ManpowerGroup
MAN
$2.32B
$188K 0.13%
+1,490
New +$186K
TKR icon
139
Timken Company
TKR
$9.79B
$188K 0.13%
3,832
-2,136
-36% -$103K
WY icon
140
Weyerhaeuser
WY
$17B
$188K 0.13%
5,343
-2,846
-35% -$101K
BERY
141
DELISTED
Berry Global Group, Inc.
BERY
$188K 0.13%
3,484
-2,035
-37% -$111K
ETFC
142
DELISTED
E*Trade Financial Corporation
ETFC
$188K 0.13%
3,792
+3,759
+11,391% +$173K
AAP icon
143
Advance Auto Parts
AAP
$3.22B
$187K 0.13%
1,875
+1,868
+26,686% +$172K
AAPL icon
144
Apple
AAPL
$4.72T
$187K 0.13%
+4,420
New +$185K
ADNT icon
145
Adient
ADNT
$1.58B
$187K 0.13%
+2,376
New +$192K
BIIB icon
146
Biogen
BIIB
$29.6B
$187K 0.13%
586
+533
+1,006% +$171K
DHC
147
Diversified Healthcare Trust
DHC
$2.23B
$187K 0.13%
9,763
-1,432
-13% -$27.4K
DLTR icon
148
Dollar Tree
DLTR
$22.6B
$187K 0.13%
+1,747
New +$171K
FL
149
DELISTED
Foot Locker
FL
$187K 0.13%
+3,991
New +$149K
GPC icon
150
Genuine Parts
GPC
$16.5B
$187K 0.13%
+1,967
New +$180K
4 5
6
7 8

Similar funds

LAM
Lyxor Asset Management New York $8.58M AUM 3.07% 1-Year Est. Return
SPCP
Snow Park Capital Partners New York $3.17M AUM 3.35% 1-Year Est. Return
GZ
George Zachary $2.34M AUM 5.28% 1-Year Est. Return
RGNCM
R.G. Niederhoffer Capital Management New York $11.3M AUM
FCM
Force Capital Management New York $11.4M AUM 5.65% 1-Year Est. Return
DCM
Dynamic Capital Management St. Helier, Jersey $12M AUM 0.65% 1-Year Est. Return
DAL
David A. Lorber $1.11M AUM 4.74% 1-Year Est. Return
SAM
Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

TLP Group's Q4 2017 Portfolio in Review

As of Q4 2017, TLP Group held 794 positions worth $144M, down 9.4% from $159M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

TLP Group's Q4 2017 filing shows 229 new, 159 increased, 207 reduced and 182 closed positions. Its largest new stake was iShares Biotechnology ETF: 4,800 shares worth $512K. The largest sale was Aimmune Therapeutics, an estimated $30.2M.

By sector, the portfolio is most concentrated in Healthcare at 8.7% of assets, up from 4.8% a quarter earlier, followed by Financials and Consumer Discretionary.

  • TLP Group's largest Q4 2017 buy was iShares Biotechnology ETF: 4,800 shares worth $512K.
  • TLP Group added most to iShares Russell 2000 ETF in Q4 2017, an estimated $3.53M increase.
  • TLP Group's biggest Q4 2017 reduction was Aimmune Therapeutics, cutting an estimated $30.2M.
  • TLP Group fully exited Daseke, Inc. Warrant in Q4 2017, selling an estimated $417K.
  • TLP Group's ten largest holdings make up 64% of its $144M portfolio in Q4 2017.
  • TLP Group opened 229 new positions and closed 182 in Q4 2017.
  • TLP Group's portfolio value fell 9.4% quarter-over-quarter to $144M.

Based on TLP Group's 13F filing for Q4 2017, filed 14 Feb 2018.